Using a genetically engineered mouse model, it was found that deletion of Brca2 in prostate epithelia resulted in focal hyperplasia and low-grade prostate intraepithelial neoplasia (PIN) in animals over 12 months old. This evidence concerns the gene BRCA2 and prostate intraepithelial neoplasia.